Physician profile
Milind Panse
NPI 1457362394
$33,635.69
in general payments reported to CMS, 2019-2025
24 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $305 · 2021: $464 · 2022: $5,586 · 2023: $253 · 2024: $260 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389 · Travel and Lodging: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.51 |
| Travel and Lodging | $462.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $20,064.30 | 2019-2022 | |
| Maxx Health INC | $10,317.76 | 2019-2022 | |
| Stryker Corporation | $663.18 | 2019-2025 | Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $621.04 | 2023-2025 | Oxford, Oxford Partial Knee, Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $461.80 | 2019-2024 | Orthovisc, Monovisc |
| Globus Medical, INC. | $256.89 | 2019-2024 | Ankle Fracture System, Distal Radius II |
| Abbvie INC. | $153.35 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $143.94 | 2019-2023 | Euflexxa |
| Abbott Laboratories | $137.50 | 2019 | |
| Ucb, INC. | $122.32 | 2025 | Zilbrysq |
| Sanofi-Aventis U.S. LLC | $112.92 | 2019-2020 | |
| Vision Quest Industries INC. | $111.85 | 2024 | Oactive Align Custom R, Bionicare Align Prefab R |
| Uoc USA INC | $96.00 | 2021 | |
| Bioventus LLC | $59.63 | 2019-2020 | |
| Heraeus Medical, LLC. | $58.86 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $55.26 | 2022 | |
| Orthalign INC | $42.46 | 2022 | |
| Smith+Nephew, INC. | $36.00 | 2021 | |
| Kci USA, INC. | $25.69 | 2023 | Prevena |
| Orthofix Medical, INC. | $23.92 | 2024 | Physio-Stim |
| Si-Bone, INC. | $23.05 | 2022 | |
| Acell, INC. | $16.90 | 2020 | |
| Medical Device Business Services, INC. | $16.14 | 2023 | Velys |
| Pacira Therapeutics, INC. | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milind Panse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.